Professor George Lewith, Professor of Health Research at the University of Southampton recently gave a presentation at the All Party Parliamentary Group for Integrated Healthcare about the current challenges of growing antimicrobial resistance and discussed possible solutions including clinical trials in the CAM field.
Society Directors Miranda Parsons and Kiran Grover, Chief Executive Mark Taylor and Professional Standards Manager Victoria Garratt attended the presentation on behalf of Society members.
Antimicrobial resistance is widely considered to pose one of the greatest risks to modern medicine.
Without antimicrobials, chemotherapy for cancer and invasive operations would become increasingly dangerous due to the likelihood of infection. Antimicrobial resistance has the potential to send medicine back to the early 20th century, severely limiting the use of what are now considered basic and routine surgical procedures.
The Government appears to recognise this threat to society and has produced its Five Year Antimicrobial Resistance Strategy. However, the strategy seems to rely mainly on encouraging the pipeline for new drugs. If the Government's strategy included exploration of, and research into, less orthodox approaches, it is felt it could avert antibiotic prescriptions for upper respiratory tract infections in primary care, a major source of antibiotic resistance, amongst other things.
At the House of Commons and Science and Technology' s inquiry into Antimircobial Resistance in the last Parliament, a number of herbal and homeopathic organisations made submissions and Professor Dame Sally Davies, the Chief medical Officer, highlights this as a key priority area.